Effect of vitamin D supplementation on control of gestational diabetes

Phase 3

• Conditions: Gestational Diabetes Mellitus.; Diabetes Mellitus in pregnancy

• Registration Number: IRCT20130616013678N29
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 23 April 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Detection of gestational diabetes between 24-28 weeks of pregnancy
Tend to participate in the study
Age category between 18-40 years old
Consumption of daily multivitamins

Exclusion Criteria

Twin or multiple pregnancy
Having a body mass index greater than 40
Consumption of Vitamin D supplementation at least three months before the intervention
Consumption of Insulin or Metformin
People with cardiovascular diseases, digestive disorders, hypertension, inflammatory diseases and hypothyroidism
Using cigarette and alcohol due to the effect on insulin metabolism and lipid profile

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
25 Hydroxy Vitamin D3. Timepoint: Before and 6 weeks after trials. Method of measurement: ElectroChemi Luminescence method.;Fasting Blood Sugar. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Serum Insulin. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.;Total Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Triglyceride. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;LDL Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;HDL Cholesterol. Timepoint: Before and 6 weeks after trials. Method of measurement: Enzymatic method.;Growth Hormone. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.;Insulin Like Growth Factor-1. Timepoint: Before and 6 weeks after trials. Method of measurement: ELISA method.